System Kirche - Machtausübung zwischen Idee, Interesse und Institution

Por Ludwig, Johannes
Publicado em 2022

Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis

Por Dendy, Meaghan S., Ludwig, Johannes M., Kim, Hyun S.
Publicado no Oncotarget (2017)

Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury

Por Ludwig, Johannes Maximilian, Zhang, Yuling, Chamulitrat, Walee, Stremmel, Wolfgang, Pathil, Anita
Publicado no PLoS One (2018)

The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imagin...

Por Ludwig, Johannes M., Camacho, Juan C., Kokabi, Nima, Xing, Minzhi, Kim, Hyun S.
Publicado no Diagnostics (Basel) (2015)

Immuno-thermal ablations – boosting the anticancer immune response

Por Slovak, Ryan, Ludwig, Johannes M., Gettinger, Scott N., Herbst, Roy S., Kim, Hyun S.
Publicado no J Immunother Cancer (2017)

SW43‐DOX ± loading onto drug‐eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment – An in vitro evaluation

Por Ludwig, Johannes M., Gai, Yongkang, Sun, Lingyi, Xiang, Guangya, Zeng, Dexing, Kim, Hyun S.
Publicado no Mol Oncol (2016)

In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma—A pilot study

Por Lahti, Steven, Ludwig, Johannes M., Xing, Minzhi, Sun, Lingyi, Zeng, Dexing, Kim, Hyun S.
Publicado no PLoS One (2017)

Oncolytic virus immunotherapy: future prospects for oncology

Por Raja, Junaid, Ludwig, Johannes M., Gettinger, Scott N., Schalper, Kurt A., Kim, Hyun S.
Publicado no J Immunother Cancer (2018)

Targeted Yttrium 89-Doxorubicin Drug-Eluting Bead—A Safety and Feasibility Pilot Study in a Rabbit Liver Cancer Model

Por Ludwig, Johannes M., Xing, Minzhi, Gai, Yongkang, Sun, Lingyi, Zeng, Dexing, Kim, Hyun S.
Publicado no Mol Pharm (2017)

Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling

Por Pathil, Anita, Mueller, Jan, Ludwig, Johannes M, Wang, Jiliang, Warth, Arne, Chamulitrat, Walee, Stremmel, Wolfgang
Publicado no Br J Pharmacol (2014)

Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy

Por Adam, Lucas C., Raja, Junaid, Ludwig, Johannes M., Adeniran, Adebowale, Gettinger, Scott N., Kim, Hyun S.
Publicado no J Immunother Cancer (2018)

Infiltrative Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Treated With a Single High-Dose Y90 Radioembolization and Subsequent Liver Transplantation Without a Recurre...

Por Dendy, Meaghan S., Camacho, Juan C., Ludwig, Johannes M., Krasinskas, Alyssa M., Knechtle, Stuart J., Kim, Hyun S.
Publicado no Transplant Direct (2017)

Genomic mutations and histopathologic biomarkers in Y(90) radioembolization for chemorefractory colorectal liver metastases

Por Dendy, Meaghan S., Ludwig, Johannes M., Kokabi, Nima, Stein, Stacey M., Lacy, Jill, Hochster, Howard S., Kim, Hyun S.
Publicado no Oncotarget (2018)

Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study

Por Prieto, Veronica, Ludwig, Johannes M., Farris, Alton B., Nagaraju, Ganji Purnachandra, Lawal, Taoreed O., El-Rayes, Bassel, Kim, Hyun S.
Publicado no PLoS One (2017)

Switching the Post-translational Modification of Translation Elongation Factor EF-P

Por Wolfram Volkwein, Ralph Krafczyk, Pravin Kumar Ankush Jagtap, Marina Parr, Marina Parr, Elena Mankina, Jakub Macošek, Jakub Macošek, Zhenghuan Guo, Maximilian Josef Ludwig Johannes Fürst, Maximilian Josef Ludwig Johannes Fürst, Miriam Pfab, Dmitrij Frishman, Dmitrij Frishman, Janosch Hennig, Kirsten Jung, Jürgen Lassak
Publicado em 2019-05-01